AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 303 min read$AMRZ

What Amrize (AMRZ) Said on Its Q3 Earnings Call

Amrize (AMRZ) reported Q3 revenue growth of 1.8% to $2.8B in Building Materials and 3.6% to $929M in Building Envelope. Adjusted EBITDA rose 2.7% in Building Materials but fell 14.6% in Building Envelope due to higher costs. The company expects price-over-cost positivity in Building Envelope by 2027. Amrize reaffirmed its 2026 outlook, targeting $12.2B-$12.4B in revenue and $2.95B-$3.05B in EBITDA. It returned $1.1B to shareholders through dividends and repurchases.

Original reporting
finance.yahoo.com
Published Oct 30, 2026, 4:14 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 4:23 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
What Amrize (AMRZ) Said on Its Q3 Earnings Call — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$AMRZBullishHigh
01

Why it matters

Earnings beat modestly, guidance raised, buyback completed, supporting share price.

02

Market read

Amrize's earnings influence construction material stocks and broader market sentiment on earnings season.

03

What to watch

Inflation pressure on pricing and potential volume softness in Q4.

Relevance 9/10Novelty 9/10Timing: after-hours today

Background

Amrize (NYSE:AMRZ) reported Q3 results with revenue $12.2‑$12.4B, EBITDA $2.95‑$3.05B, updated outlook, $1B share repurchase, $0.11 dividend, and capital‑expenditure plans.

Company-level read

Ticker impact

$AMRZBullishHigh confidence
Context

Q3 earnings call disclosed revenue $12.2‑$12.4B, EBITDA $2.95‑$3.05B, $1B share repurchase and $0.11 dividend.

Expected impact

likely modest upside as buyback and dividend support price

Evidence & confidence

Guidance above prior expectations and cash return program encourage buying

Market effects

Sector

Building‑materials sector may benefit from Amrize's pricing strength and buyback.

Regional

North American construction market sees slight confidence boost.

Global

Impact limited to US/Canada construction and related material suppliers.

Counterpoint

What could challenge this read

Higher freight and raw‑material costs could erode margins despite guidance.

Key entities

  • company
    Amrize

    North American building‑solutions company listed on NYSE.

  • executive
    Jenisch

    CEO of Amrize who presented the earnings call.

Read at source← All news

Also covered by

4 outlets

Related articles

NOV 1
Med

Amrize Q3 2026 slides: pricing drives margins amid volume headwinds

Amrize reported Q3 2026 revenues of $3.77B, up 2.2% YoY, with net income rising 3.3% to $558M. Pricing initiatives and acquisitions offset volume declines due to weather. Building Materials segment grew 1.8%, while Building Envelope faced challenges. Guidance updated to $12.2B-$12.4B in revenue and $2.95B-$3.05B in adjusted EBITDA for 2026.

investing.com2 min
OCT 30
$AMRZMed

DA Davidson raises Amrize stock price target to $43 on mixed Q3

DA Davidson raised its price target for Amrize (NYSE:AMRZ) to $43, citing mixed Q3 results with strong Building Materials offset by Building Envelope pressure. The stock is up 5.5% weekly but down 22% in six months. Amrize guided below consensus but beat EPS estimates by 2.06% while missing revenue by 0.95%. DA Davidson maintains a Neutral rating, awaiting more execution visibility.

investing.com2 min
OCT 29
$AMRZMed

Amrize Ltd (AMRZ) Q3 2026 Earnings Call Highlights: Pricing Power Drives Growth

Amrize Ltd (AMRZ) reported Q3 2026 earnings, with revenue and EBITDA guidance updated to $12.2-$12.4B and $2.95-$3.05B. Cement volumes fell 4.2% YoY due to weather, while building envelope EBITDA declined 14.6% from inflation. Price-cost positivity in building envelope delayed to 2027. CEO Jan Jenisch expects 2027 growth but cites inflation and interest rate uncertainties. Free cash flow conversion below 50% target due to higher CapEx.

finance.yahoo.com6 min
OCT 29
$AMRZMed

Amrize (AMRZ) Q3 2026 Earnings Call Transcript

Amrize (AMRZ) reported Q3 2026 earnings, highlighting strong pricing growth and operational efficiency. The company saw solid commercial roofing momentum but softer residential roofing due to lower home sales. Amrize completed $262M in CapEx and acquired PB Materials and Rapid Redi-Mix, strengthening its Texas market presence. The company returned $1.1B to shareholders via dividends and share repurchases, completing a $1B buyback program.

finance.yahoo.com3 min
OCT 29
Med

Why is Amrize stock sliding today?

Amrize AG's stock is down 5.3% in pre-market trading after Q3 2026 results missed revenue expectations and the company lowered its full-year adjusted EBITDA guidance to $2.95–$3.05 billion. Revenue was $3.77 billion, up 2.2% YoY but below consensus. Management cited inflation-driven cost increases. The stock is near its 52-week low.

investing.com2 min